Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connor Frey

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Affective Disorders|January 11, 2025
Quetiapine is associated with pancreatitis: A real-world pharmacovigilance studyConnor Frey
Rheumatology International|May 23, 2026
Dermatomyositis predominates among checkpoint inhibitor-associated inflammatory myositis phenotypes: a pharmacovigilance disproportionality analysis identifies a class-wide signalConnor Frey
Canadian Journal of Physiology and Pharmacology|May 7, 2026
Pseudolymphoma Associated with Calcium Channel Blockers: A FAERS Disproportionality Analysis Comparing Dihydropyridines and Non-DihydropyridinesConnor Frey
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 5, 2026
Disproportionality Analysis of Tirzepatide-Associated KetoacidosisConnor Frey
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 26, 2025
Consistent Patterns of Immune-Related Adverse Events in Postmortem and Real-World Data on Immune Checkpoint InhibitorsConnor Frey
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2026
Comparative pharmacovigilance signals for PD-1, PD-L1, CTLA-4, and LAG-3 immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in the FAERS databaseConnor Frey
Future Oncology (London, England)|April 3, 2026
GLP-1 receptor agonists and immune checkpoint inhibitor therapy: a narrative review on mechanistic and clinical evidenceConnor Frey
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2026
Pharmacovigilance analysis of the FGFR inhibitor futibatinib using the FDA adverse event reporting system (FAERS) databaseConnor Frey
Leukemia & Lymphoma|May 28, 2026
Cytomegalovirus reactivation associated with CD20 × CD3 bispecific T-cell engagers: a frequentist and Bayesian analysis of a large national databaseConnor Frey
Leukemia Research|June 18, 2026
CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide databaseConnor Frey
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Affective Disorders|January 11, 2025
Quetiapine is associated with pancreatitis: A real-world pharmacovigilance studyConnor Frey
Rheumatology International|May 23, 2026
Dermatomyositis predominates among checkpoint inhibitor-associated inflammatory myositis phenotypes: a pharmacovigilance disproportionality analysis identifies a class-wide signalConnor Frey
Canadian Journal of Physiology and Pharmacology|May 7, 2026
Pseudolymphoma Associated with Calcium Channel Blockers: A FAERS Disproportionality Analysis Comparing Dihydropyridines and Non-DihydropyridinesConnor Frey
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 5, 2026
Disproportionality Analysis of Tirzepatide-Associated KetoacidosisConnor Frey
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 26, 2025
Consistent Patterns of Immune-Related Adverse Events in Postmortem and Real-World Data on Immune Checkpoint InhibitorsConnor Frey
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2026
Comparative pharmacovigilance signals for PD-1, PD-L1, CTLA-4, and LAG-3 immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in the FAERS databaseConnor Frey
Future Oncology (London, England)|April 3, 2026
GLP-1 receptor agonists and immune checkpoint inhibitor therapy: a narrative review on mechanistic and clinical evidenceConnor Frey
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2026
Pharmacovigilance analysis of the FGFR inhibitor futibatinib using the FDA adverse event reporting system (FAERS) databaseConnor Frey
Leukemia & Lymphoma|May 28, 2026
Cytomegalovirus reactivation associated with CD20 × CD3 bispecific T-cell engagers: a frequentist and Bayesian analysis of a large national databaseConnor Frey
Leukemia Research|June 18, 2026
CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide databaseConnor Frey
Pageof 4